| 1 |
What is the main advantage of using nanomaterials in electrochemical sensors for medical diagnostics?
|
3. They enhance sensitivity and surface area for detection |
|
Nanomaterials like gold nanoparticles, quantum dots, or graphene have a high surface area to volume ratio which enables them to have higher density of biomolecular interactions do they could enhacne the sensors sensitivity.
|
I found it on the enhancing sensitivity and specificity part which is located on the 6.1 and 6.1.1 part of the subheading on page 15
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following nanomaterials is frequently mentioned as enhancing sensor conductivity?
|
2. Gold nanoparticles |
|
Gold nanoparticles are frequently highlighted to enhance conductivity in electrochemical sensors. They have large surface area to volume ration it also increases electron transfer and improve sensitivity and signal
|
I found it on page 7 of the article on the subheafing 3.2 key nanomaterials used in electrochemical sensors.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why are carbon-based nanomaterials such as carbon nanotubes (CNTs) useful in electrochemical sensors?
|
3. They improve electron transfer and mechanical strength |
|
CNTs are widely used in electochemical sensors because they improve electron trander, they are clyndrical nanostructures with good electrical mechanicla and thermal properties. CNTs are faster and has a more sensitive detection of biomolecules. They also improve electron transer because of their electrical conductivity.
|
I found it on the subheafing key nanmaterials used in electrochemical sensors 3.2 on page 7
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What is one challenge in integrating nanotechnology with electrochemical sensors for medical use?
|
3. Issues in reproducibility and standardization |
|
The article hihglighted reproducibility and standardization because it affects medical uses regulartory approval technical and market barriers. WHich means their manufacturing consistency is bad. Nanomaterials can vary in shape and size it becomes difficult to produce sensors that have reliable performance.
|
I found it on page 1 in the abstract part and page 11 4.3.1 technical challenges
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
Which technique is commonly used to enhance the signal in nanotechnology-based electrochemical sensors?
|
2. Enzyme labeling |
|
nanomateeials like gold silver or platinum uses catalic properties and provides active sites for niomolecule attachment to improve sensitivity.
|
In 1.3.1 in page 3 ehancing sensitivity and specification and 3.2 key nanomaterials used in electrochemical sensors page 7
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why is biocompatibility crucial in designing electrochemical sensors for medical diagnostics?
|
2. To prevent rejection or toxicity in biological systems |
|
biocompatibility ensures that the sensors materials dont trigger other reactions in the human body. Materials like biodegradble polymers help in safe sensor applications.
|
I found it on page 7 in 3.3 properites of nanmaterials relevant to sensing
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
How do label-free electrochemical sensors differ from labeled ones?
|
3. They do not rely on additional reagents or markers |
|
Label free elecrochemical sensors detect analytes directly without needing to fluorescent dyes or enzymes which simplify costs sensing process and helps with real time monitoring
|
I found it on 2.1 label free detection methods and table 1 comparison labeled free verseus labeled approaches
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What is one promising application of nanotech-based electrochemical sensors?
|
2. Early detection of disease biomarkers |
|
Nanotechnology sensors can detect biomarkers like dna rna at low levels allowing for early signosis of cancer or other sideases which is crucial for better patient outcomes.
|
I found it on section 6.3 point o f care applications and early detection.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
Which of the following factors most directly affects the sensor's detection limit?
|
2. Nanomaterial surface-to-volume ratio |
|
Havinf a high surface to volume ration helps provide more active sites for interactions with molecules which increases detection at low level of concentrations reducting detection limit and increasing accuracy of early stage diagnosis.
|
I found it on 6.1.1 wnhancements in sensitivity.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What is one of the primary goals of using digital sensing technologies in cancer care?
|
3. Enable earlier and more personalized diagnosis |
|
digital sensing enables us to monitor continuously and enabling early detecion of abnomal problems and inventing treatmetns to individual patient profiles which helps dhift medical cancer care by improveing outcomes adn reduces unecessary intervntins.
|
It is mentioned trhoughout the aritcle even in the abstract part that goals are ro provide early detection to improve diagnostic accuracy and personalized treatments
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
Which type of sensor is often used to monitor physical activity in cancer patients?
|
3. Accelerometers |
|
Accelerometers track physical activity levels in cancer patients. They provide clinicians with data on mobility, helping to evaluate treatment impact and recovery. They are especially useful in remote patient monitoring systems.
|
I found it on the part where it talks aboutmonitpring physical activity
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Why are patient-reported outcomes important in digital cancer care systems?
|
2. They assist in dose calibration of radiotherapy |
|
PROs help with the persons personal experiences like pain fatigue wihich cannot be detected with sensors and when they combone with objective sesnor data they offer a view of the patients condition
|
i found it on 7.3 where it talks about safety concerns and market barriers
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What is one major advantage of real-time digital sensing in cancer treatment?
|
3. Rapid detection of deterioration in patient condition |
|
Real time monitoring helps detect early signs of health problems Timely alerts enable immediate intervention, potentially preventing hospitalizations.
|
3.2 talks about advantages of digital snsor in cancer treatment so i got it from there
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Which of the following is a key barrier to implementing digital sensing in routine oncology practice?
|
3. Limited digital literacy among patients and providers |
|
By having successful use of digital tools requires users to to understand and know hoe to operate it which could be hard gor epeople who have limited literaacy and reduce the effdctiveness of this technolofy .
|
i found it on subheading 7 onwards talks about challenges
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
Which stakeholders are considered central to the adoption of digital cancer care platforms?
|
2. Patients and healthcare providers |
|
Patients and clinicians are the most important people of digital cancer care platforms. Their participation, feedback, and trust are important for long tern use adn ensuring successful treatments.
|
MOstly the article talks about personalized treatment care adn accuracy so by consideraing that patients are important to get the data needed for personalized treatment options.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Digital sensing systems collect which combination of data types for cancer care optimization?
|
2. Sensor metrics and patient-reported outcomes |
|
Ojective sensor data and pate=ient reports or outcomes helps understand health status which allows clnicans to provide better and responsive care.
|
The article mentions about improving healthcare like personalized treatmetns so i can infer that they would collect patient outcomes to analyze and digital sensing systems usually find data types for specificity.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
How do digital sensors contribute to improving the quality of life in cancer patients?
|
3. By enabling symptom tracking and early intervention |
|
MOnitoring symptoms in real time helps people like clinicans to help early reducing discomfort and avoiding difficult complications whihc overall enhnces the patients well ebing
|
I found it in sunheading 6 where it takes about the advantages of digital sensing
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What does the article suggest about the future direction of digital sensing in cancer care?
|
3. It holds promise for widespread personalized care |
|
The article emphasizes digital sensing apply with futurea pplications with strong potential to support personal cancer treatment throughout many clincal care settings
|
I found it in the abstract part where it emphasizes of future and promises
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
Based on the diagram, which of the following would most likely result in a false signal output in an electrochemical sensor for medical diagnostics?
|
1. Using a transducer made of non-conductive materials |
|
The transducer is used for converting biochemical signals into measurable electrical outputs. Using a non conductive material would not allow signal transmission which can lead to inaccurate readings
|
I found it on figure 1 on page 2 basic principles of electromehanical biosnesors andd used the information of 1.2 all the way to 1.2.3
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
Based on the image, which of the following scenarios best demonstrates the advantage of using emerging digital platforms in cancer diagnostics?
|
3. A portable chip-based sensor detects protein biomarkers from a blood sample within minutes |
|
Miniaturized sensors jelp by giving fast point-of-care diagnosisthat are important for early detection and continuous monitoring in oncology. These platforms reduce the need for lab testing and improve accessibility.
|
I found it on the section 6.3 about real time moniotring
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|